ANI PHARMACEUTICALS, INC Goodwill, Acquired During Period
ANI PHARMACEUTICALS, INC (ANIP) reported Goodwill, Acquired During Period of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2020-02-27
- ANI PHARMACEUTICALS, INC goodwill, acquired during period for the quarter ending 2013-12-31 was $0.00.
- ANI PHARMACEUTICALS, INC goodwill, acquired during period for the quarter ending 2013-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC goodwill, acquired during period for the quarter ending 2013-06-30 was $1.80M.
- ANI PHARMACEUTICALS, INC goodwill, acquired during period for the quarter ending 2012-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC goodwill, acquired during period for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- ANI PHARMACEUTICALS, INC goodwill, acquired during period for fiscal 2018 was $1.74M.
- ANI PHARMACEUTICALS, INC goodwill, acquired during period for fiscal 2017 was $0.00.
- ANI PHARMACEUTICALS, INC goodwill, acquired during period for fiscal 2013 was $1.80M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 6 month as first filed | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 9 month as first filed | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | |||||
| 2018-12-31 | $1.74M 10-K · filed 2020-02-27 | |||||
| 2017-12-31 | $0.00 10-K · filed 2019-02-27 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $0.00 derived: sum of 2 quarters · filed 2015-02-23 | $1.80M derived: sum of 3 quarters · filed 2015-02-23 | $1.80M 10-K · filed 2015-02-23 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.80M derived: sum of 2 quarters · filed 2014-11-10 | $1.80M 10-Q · filed 2014-11-10 | $1.84M 10-Q · filed 2013-11-07 | ||
| 2013-06-30 | $1.80M 10-Q · filed 2014-08-07 | $1.80M 10-Q · filed 2014-08-07 | $1.84M 10-Q · filed 2013-08-09 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |